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Abstract
Background: Poor awareness and knowledge of Chlamydia trachomatis could be a barrier to uptake of screening.
This study aimed to determine the level of awareness and knowledge of chlamydia among young people who
were being approached in a variety of community settings and offered opportunistic screening.
Methods: Men and women aged 16-24 years were approached in education, health and fitness, and workplace
settings and invited to complete a self-administered questionnaire then provide a urine sample for chlamydia
testing. Follow-up semi-structured interviews with 24 respondents were carried out after test results were received.
Results: 363 questionnaires were completed (43.5% from men). Whilst awareness of chlamydia was high,
knowledge decreased as questions became increasingly focussed so that around half of respondents were
unaware of the asymptomatic nature of chlamydia infections. Men’s knowledge of symptoms was consistently
lower than women’s, with most men failing to identify unusual discharge as a symptom in men (men 58.3%,
female 45.8%, p = 0.019); fewer men knew unusual discharge was a symptom among women (men 65.3% female
21.4%, p < 0.001). The asymptomatic nature of the infection resonated with respondents and was the commonest
piece of information they picked up from their participation in the study.
Conclusions: Despite scientific gains in understanding chlamydia infection, public understanding remains limited.
Greater efforts are required to translate scientific evidence to the public. An improvement in knowledge may
maximise gains from interventions to improve detection.
Background
Chlamydia trachomatis is the most common bacterial
sexually transmitted infection in the UK [1], with a high
estimated population prevalence of 3%, rising to around
10% among young people aged under 25 years [2-4],
and high transmission potential [5,6]. In 2008 there
were 83, 214 diagnoses of chlamydia in the UK (among
those aged under 25 years), a slight increase from 81,
652 in 2007[7].
The opportunistic approach to screening, as recom-
mended by screening guidelines for Scotland [3] and as
undertaken in England as part of the National Chlamy-
dia Screening Programme (NCSP) has been criticised as
‘unlikely to be sufficient to control the spread of
chlamydia’ due to ‘low annual coverage and infrequent
screening’ [8]. The most recent data for the English
NCSP revealed an overall coverage of 15.9% among 15-
24 year olds between April 2009 -December 2009 [9],
which is lower than 30-40% effective screening rate
among those aged under 25 years estimated in a
National Institute for Health and Clinical Excellence
(NICE) rapid review as necessary to effect a reduction in
prevalence [10,11]. This failure to reach young people is
occurring despite the introduction of non-invasive tests,
which has created new opportunities for screening in a
variety of non-medical settings, such as: student bars
[12]; in field settings (such as parks, street corners and
areas where youth congregate)[13]; mobile clinics [14];
schools and universities [15-17]; health and fitness and
workplace settings [18]; as well as enabling postal testing
from community pharmacies [19] and in the home set-
ting [20-22]. One reason for this might be that despite
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scientific gains in understanding chlamydia infection,
public understanding of chlamydia remains limited.
Qualitative studies have reported: some young people
think they can die from having chlamydia [23]; belief
that it is a ‘woman’s disease’ [24,25]; belief that the test
is painful and invasive [24,26]; and perceptions that only
‘slappers’ and ‘dirty’ people contract chlamydia
[24,26-29].
Poor knowledge could obstruct the effectiveness of
any screening approach, as young people are unlikely to
take up the offer of screening if they are unaware of key
clinical features, such as the largely asymptomatic nature
of the infection and associated sequelae. It is therefore
important to continue to assess and monitor levels of
awareness and knowledge of chlamydia so as to better
communicate messages about chlamydia to young peo-
ple. Where there are no national screening programmes
(such as in Scotland) better ways to inform young peo-
ple will be required. This study aimed to determine the
level of awareness and knowledge of chlamydia among
young people who were approached in a variety of com-
munity settings in Glasgow, Scotland and offered oppor-
tunistic screening, by urine sample. The willingness of
young people to accept the offer of screening and pro-
vide a urine sample is reported elsewhere [18,26]; this
paper reports the knowledge of those respondents.
Methods
Young people aged 16-24 years were approached in a
large further education college [in the UK these voca-
tional institutions are a level above compulsory educa-
tion but below university], health and fitness (local
authority-run facilities rather than private gyms), and
workplace settings (two call centres - office environ-
ments that provided non-specialist telephone-based con-
sumer services for energy companies) and invited to
take part in a chlamydia screening study. A convenience
sample was employed, due to the way in which young
people used the settings which prohibited a more sys-
tematic approach (further detail is provided elsewhere
[18]).
The study took place over the course of 4 weeks in
each setting (between October 2004 - April 2005). One
week prior to, and throughout, the study, posters placed
around the study venues provided information about
chlamydia. Young people who appeared age-eligible
were approached: in the main canteen in the education
setting; in the main foyers of the health and fitness set-
tings; and, in a kitchen/’chill-out’ area of the two contact
centres. The lead author (KL) approached young people,
established their age for eligibility, explained the study
to them and informed them about chlamydia (verbally,
and by giving them a study leaflet - see Additional file 1
study leaflet). The leaflet provided information on what
chlamydia is, possible male and female symptoms and
that the test can be performed on a sample of urine.
Willing participants provided written consent and were
requested to complete a self-administered questionnaire,
which asked for their knowledge of chlamydia and their
views on screening. Participants were to complete the
questionnaire immediately in the location (e.g. at their
table in the canteen) and return it to the researcher. In
practice a few participants in the workplace setting took
the questionnaire away and returned it within an hour
or two. Privacy levels for participants completing a ques-
tionnaire varied across the settings, with large numbers
of people using the education setting canteen area com-
pared to the commonly quiet location of the health and
fitness main foyers.
Upon returning the questionnaire participants were
invited to provide a urine sample for chlamydia testing -
they could decline and remain in the study. Throughout
fieldwork, a record of the number of people approached
was made, as well as general observations of young peo-
ple’s non-verbal response to the offer of chlamydia
screening being noted in fieldwork diaries (e.g. young
women hiding their samples in jacket pockets).
The questionnaire (see Additional file 2 questionnaire)
captured respondents’ knowledge of chlamydia, views
towards screening, sexual behaviour and willingness to
provide a urine sample in the setting. The knowledge
section of the questionnaire contained 17 items. Four
questions asked how infection occurs, symptoms asso-
ciated with chlamydia infection in women and symp-
toms among men (choosing from a list of symptoms),
and testing method. From eleven statements to which
respondents could answer ‘True’, ‘False’ or ‘Not sure’
(table 1), a mean knowledge score was calculated (one
point for a correct answer, 0 for an incorrect answer,
answering not sure or providing no answer). The maxi-
mum score achievable was 11. Respondents were also
asked to respond to two statements: ‘I’d know if I had
chlamydia’ and ‘I’d only think about chlamydia if I had
symptoms’ (responding to a 5-point Likert scale from
Strongly Agree to Strongly Disagree).
A sub-sample of participants who completed a question-
naire and consented to take part in a follow-up inter-
view was contacted by telephone after test results had
been sent (around 1-2 weeks post test). The interviews
were designed to explore further their knowledge of
chlamydia, sexual lifestyles, views towards community-
based screening as well as reasons for accepting or
declining the offer of screening in a community setting.
Regarding knowledge, respondents were asked to
describe their awareness and knowledge of chlamydia
(including symptoms and consequences) and from
where they obtained this information (see Additional file
3 topic guide). All interviews were conducted either in a
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private room at the university or in the study setting,
and were between 30 and 90 minutes in duration. All
participants who were willing to take part in a follow-up
interview were interviewed (n = 24; 18 had provided a
sample for testing and 6 had refused).
Analysis of differences in proportions was carried out
using the c2 test, with Fisher Exact test used where
expected cell counts is less than 5. Univariate logistic
regression tested the association between knowledge
and gender. Respondents’ ages were categorised
bi-modally (16-19 years; 20-24 years). Interviews were
recorded and transcribed verbatim before being coded
using Atlas.ti (Scientific Software Development, Berlin,
Germany). Transcripts were read repeatedly for emer-
ging and recurrent themes. Respondents’ knowledge
became a focus of analysis. Due to the gendered
response when approaching respondents in the study
settings, and the gender differences in knowledge that
emerged from analysis of questionnaire data, the qualita-
tive data were examined for gender differences in
knowledge. The recurring themes identified by KL were
discussed and refined with GH. Ethics approval was
granted by the University of Glasgow Faculty of Medi-
cine Ethics Committee.
Results
A total of 363 (84%) questionnaires were completed from
all those approached: 158 (43.5%) from men and 205
(56.5%) from women; by setting, 126 (34.7%) from educa-
tion, 133 (36.6%) from health and fitness, and 104 (28.6%)
from workplace. Twenty four respondents later partici-
pated in a follow-up semi-structured interview (10 women,
14 men). By setting, 5 participated from the education set-
ting, 9 from health and fitness, and 10 from workplace.
The mean age of all participants was 20 years, with
more 16 to 19 year olds recruited from the education
setting (53.7%) than health and fitness (29.3%) or work-
place settings (23.1%).
Questionnaire responses
Awareness
The majority (93%) of respondents had heard of chlamy-
dia prior taking part in the study, with no significant
gender differences. Setting was significantly associated
with respondents having previously heard of chlamydia,
with education and workplace setting respondents more
likely to have heard of chlamydia than health and fitness
respondents (c2 test, p = 0.004). All respondents, except
one, correctly identified chlamydia as being a sexually
Table 1 True/False questions used to assess knowledge of chlamydia
Correct
response (%)
Incorrect
response
(%)
Answered
‘Not sure’
(%)
P
Value
Unadjusted
OR
(95% CI)
1. You can catch chlamydia from toilet seats (F) Male 110 (70.5) 14 (9.0) 32 (20.5) 1
Female 165 (83.8) 9 (4.6) 23 (11.7) 0.012 1.80 (1.11-2.92)
2. Men with chlamydia might not have symptoms (T) Male 100 (63.7) 19 (12.1) 38 (24.2) 1
Female 148 (74.4) 23 (11.6) 28 (14.1) 0.082 1.50 (0.96-2.35)
3. Most women will not develop symptoms of
chlamydia (T)
Male 39 (25.7) 51 (33.6) 62 (40.8) 1
Female 123 (62.4) 31 (15.7) 43 (21.8) <0.001 4.57 (2.89-7.22)
4. Only women get chlamydia (F) Male 149 (95.5) 0 7 (4.5) 1
Female 188 (94.0) 1 (0.5) 11 (5.5) 0.613 0.66 (0.29-1.54)
5. Chlamydia can affect men’s fertility (T) Male 113 (72.4) 6 (3.8) 37 (23.7) 1
Female 123 (61.5) 9 (4.5) 68 (34.0) 0.090 1.16 (0.40-3.33)
6. Chlamydia can affect women’s fertility (T) Male 121 (78.6) 2 (1.3) 31 (20.1) 1
Female 174 (87.0) 5 (2.5) 21 (10.5) 0.064 1.95 (0.37-10.1)
7. Chlamydia can cause eye infections (conjunctivitis) (T) Male 18 (11.5) 64 (41.0) 74 (47.4) 1
Female 36 (18.1) 89 (44.7) 74 (37.2) 0.084 1.12 (0.74-1.71)
8. Once you get chlamydia you can’ t get rid of it (F) Male 110 (71.0) 19 (12.3) 26 (16.8) 1
Female 169 (84.5) 17 (8.5) 14 (7.0) 0.005 2.04 (1.24-3.35)
9. You can get chlamydia more than once (T) Male 92 (59.4) 17 (11.0) 46 (29.7) 1
Female 166 (83.0) 4 (2.0) 30 (15.0) <0.001 3.05 (1.90-4.88)
10. Women’s smear tests would detect chlamydia (F) Male 16 (10.4) 52 (33.8) 86 (55.8) 1
Female 50 (25.0) 92 (46.0) 58 (29.0) <0.001 2.86 (1.56-5.25)
11. ‘The Pill’ prevents sexual infections (F) Male 127 (81.9) 5 (3.2) 23 (14.8) 1
Female 193 (96.5) 1 (0.5) 6 (3.0) <0.001 3.92 (1.94-7.92)
Correct answer in parentheses.
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transmitted infection (99.2%). The majority (99.4%) of
all study respondents correctly identified unprotected
sex (no condom) as the primary means of sexual trans-
mission. The majority of survey respondents (97.2%)
knew chlamydia could be tested using a urine sample.
Knowledge of the clinical features of chlamydia
There were a number of misconceptions in relation to
symptoms of chlamydia infection (tables 2, 3, 4, with cor-
rect symptoms in bold), with variation in level of miscon-
ception between symptoms. For symptoms of chlamydia in
women, no respondent believed dizziness was a symptom
whereas 80.2% failed to correctly identify ‘Pain in lower
stomach’ as a possible symptom. By gender (table 2),
significantly fewer women answered incorrectly than men
to: unusual discharge, pain or stinging when urinating,
pain during sex and pain in lower stomach.
For symptoms of chlamydia in men, a similar variation
in numbers answering incorrectly emerged, with no
respondent identifying dizziness as a symptom but
74.8% failing to identify pain/swelling in testicles as a
possible symptom (table 2). Significantly (c2 test p =
0.019) more men than women incorrectly responded to
‘unusual discharge’ as a symptom among men.
By setting (table 3) there was little variation in incor-
rect responses. Significantly fewer workplace respon-
dents answered incorrectly to unusual discharge and
itch and/or rash symptoms in women compared with
education and health and fitness respondents. Whilst
there was little variation in incorrect responses between
settings, when comparing responses by age groups (16-
19; 20-24 years) older respondents provided significantly
fewer incorrect responses to four of the symptoms in
women and three of the symptoms in men (table 4).
The overall mean score for the eleven ‘true/false’
statements was 6.9 (range 0-11). Women had a signifi-
cantly higher knowledge than men (mean score 7.4
compared with 6.2, respectively; c2 test p < 0.001).
Table 1 shows that respondents were more sure of
some true/false statements than others, such as knowing
that both sexes can acquire chlamydia (statement 4,
women 94.0% men 95.5%) and that ‘The Pill’ does not
prevent STIs (statement 11, women 96.5% men 81.9%).
In contrast, respondents were less sure of chlamydia
causing conjunctivitis (statement 7) with 18.1% of
women and 11.5% of men answering correctly; and that
women’s smear test do not test for chlamydia (statement
10), with 25.0% of women and 10.4% of men answering
correctly. Men provided more uncertain responses than
women to 9 of the 11 statements. Significantly more
women than men answered correctly to statement 1
(you can catch chlamydia from toilet seats, 83.8% v
70.5%, p = 0.012), statement 3 (most women will not
develop symptoms of chlamydia, 62.4% v 25.7%, p <
0.001), statement 8 (once you get chlamydia you can’t
get rid of it, 84.5% v 71.0% p = 0.005), statement 9 (you
can get chlamydia more than once, 83.0% v 59.4% p <
0.001), statement 10 (women’s smear tests would detect
chlamydia, 25.0% v 10.4% p < 0.001) and statement 11
(’The Pill’ prevents sexual infections, 96.5% v 81.9% p <
0.001) (table 1). Men’s knowledge was higher on state-
ments 4 and 5, but this did not reach significance.
More respondents disagreed (47.4%) with the state-
ment ‘I’d know if I had chlamydia’ than agreed (14.9%),
but around 1 in 3 were not sure (36.4%). There were no
differences by gender, setting or age group. Respondents
were also asked to respond to the statement ‘I’d only
think about chlamydia if I had symptoms’: most (45.5%)
disagreed, whilst a third (36.6%) agreed and 17.9% were
not sure. Men were significantly more likely to agree to
this statement (45.6% of men compared with 29.8% of
women, c2 test, p = 0.006).
Interview and participant observation data
Awareness of chlamydia
The questionnaire data revealed that the majority (93%)
of respondents had heard of chlamydia prior to taking
part in this study. However, in each of the settings,
Table 2 Number and percentage of respondents who
answered incorrectly to various symptoms of chlamydia
trachomatis infection in women and men, by gender
Symptoms in women Male
N (%)
Female
N (%)
Total
N (%)
c2test
p
Unusual discharge 96
(65.3)
43
(21.4)
139
(39.9)
<0.001
Pain or stinging when
urinating
89
(60.5)
84
(41.8)
173
(49.7)
0.001
Dizziness 0 0 0 -
Headache 0 5 (2.5) 5 (1.4) 0.054
Pain during sex 100
(68.0)
95
(47.3)
195
(56.0)
<0.001
Pain in lower stomach 133
(90.5)
146
(72.6)
279
(80.2)
<0.001
Itch and/or rash 125
(85.0)
154
(76.6)
279
(80.2)
0.052
Symptoms in men
Unusual discharge from tip of
penis
91
(58.3)
92
(45.8)
183
(51.3)
0.019
Pain and/or burning when
urinating
71
(45.5)
92
(45.8)
163
(45.7)
0.961
Dizziness 0 0 0 -
Headache 0 2 (1.0) 2 (0.6) 0.212
Pain/swelling in testicles 117
(75.0)
150
(74.6)
267
(74.8)
0.936
Itchiness around groin area 19
(12.2)
31
(15.4)
50
(14.0)
0.381
Rash 19
(12.2)
26
(12.9)
45
(12.6)
0.831
Correct symptoms are indicated by bold typeface.
Significant relationships between gender and knowledge of symptoms are
indicated by bold p-values.
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when women were approached it was common for them
to respond confidently and with certainty when asked if
they had heard of chlamydia before, for example, “Oh,
yes, uh huh, I’ve heard of it” and “Chlamydia yes I’ve
heard of it..” (Fieldnotes, Workplace, April 2005). In
contrast, men were less certain about having heard of
chlamydia, with the researcher often receiving blank
looks and being required to provide more explanation
to men than to the women about chlamydia before they
affirmed their awareness. During interviews, the survey
findings and observations were borne out: all intervie-
wees described being aware of chlamydia prior to the
posters about the study going up in the setting. What
emerged across the interviews was the superficiality of
their self-reported knowledge, with some conveying only
having heard of it.
“I’d heard of chlamydia but I didn’t know what it
was, really...”
(Interviewee #75, Male, Age 17, Education).
Table 3 Number and percentage of respondents who answered incorrectly to various symptoms of chlamydia
trachomatis infection in women and men, by study setting
Symptoms in women Education
N (%)
Health & fitness
N (%)
Workplace
N (%)
Total
N (%)
c2test
p
Unusual discharge 44 (37.3) 65 (49.2) 30 (30.6) 139 (39.9) 0.013
Pain or stinging when urinating 59 (50.0) 73 (55.3) 41 (41.8) 173 (49.7) 0.130
Dizziness 0 0 0 0 -
Headache 1 (0.8) 1 (0.8) 3 (3.1) 5 (1.4) 0.280
Pain during sex 64 (54.2) 78 (59.1) 53 (54.1) 195 (56.0) 0.668
Pain in lower stomach 100 (84.7) 106 (80.3) 73 (80.2) 279 (80.2) 0.170
Itch and/or rash 95 (80.5) 118 (89.4) 66 (67.3) 279 (80.2) <0.001
Symptoms in men
Unusual discharge from tip of penis 62 (50.8) 77 (58.3) 44 (42.7) 183 (51.3) 0.059
Pain and/or burning when urinating 58 (47.5) 67 (50.8) 38 (36.9) 163 (45.7) 0.093
Dizziness 0 0 0 0 -
Headache 1 (0.8) 1 (0.8) 0 2 (0.6) 0.664
Pain/swelling in testicles 87 (71.3) 101 (76.5) 79 (76.7) 267 (74.8) 0.551
Itchiness around groin area 17 (13.9) 17 (12.9) 16 (15.5) 50 (14.0) 0.844
Rash 16 (13.1) 11 (8.3) 18 (17.5) 45 (12.6) 0.109
Correct symptoms are indicated by bold typeface.
Significant relationships between gender and knowledge of symptoms are indicated by bold p-values.
Table 4 Number and percentage of respondents who answered incorrectly to various symptoms of chlamydia
trachomatis infection in women and men, by age group
Symptoms in women 16-19 years
N (%)
20-24 years
N (%)
Total
N (%)
c2test
p
Unusual discharge 57 (44.5) 82 (37.6) 139 (40.2) 0.205
Pain or stinging when urinating 73 (57.0) 100 (45.9) 173 (50.0) 0.045
Dizziness 0 0 0 -
Headache 5 (3.9) 0 5 (1.4) 0.003
Pain during sex 87 (68.0) 108 (49.5) 195 (56.4) 0.001
Pain in lower stomach 118 (92.2) 159 (72.9) 277 (80.1) <0.001
Itch and/or rash 106 (82.8) 171 (78.4) 277 (80.1) 0.326
Symptoms in men
Unusual discharge from tip of penis 75 (58.6) 107 (47.3) 182 (51.4) 0.042
Pain and/or burning when urinating 68 (53.1) 95 (42.0) 163 (46.0) 0.044
Dizziness 0 0 0 -
Headache 2 (1.6) 0 2 (0.6) 0.059
Pain/swelling in testicles 106 (82.8) 158 (69.9) 264 (74.6) 0.007
Itchiness around groin area 20 (15.6) 30 (13.3) 50 (14.1) 0.542
Rash 10 (7.8) 34 (15.0) 44 (12.4) 0.048
Correct symptoms are indicated by bold typeface. Significant relationships between age group and knowledge of symptoms are indicated by bold p-values.
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Knowledge of chlamydia
When asked in more detail about their knowledge, most
interviewees spoke of their knowledge in tentative vague
terms:
I: Tell me what you know about chlamydia.
R: I don’t know a lot about it to be honest [pause].
See, I’ve heard about it, I don’t really know,
obviously, all the ins and outs of it, but I know what
it is, as much as I kinda, I think I know kind of
thing, but em...I don’t know a lot about it.
(Interviewee #309, Female, Age 20, Workplace).
Only two interviewees had more detailed knowledge
about chlamydia: one had worked in a laboratory which
tested samples for STIs and the other had experience of
working on a sexual health advice line. Both intervie-
wees understood the largely asymptomatic nature of
chlamydia and the possible effects on fertility.
Interviewees frequently contextualised their own poor
knowledge of chlamydia by reference to the absence of
knowledge regarding this topic on the part of young
people in society generally. The young woman quoted
above offered the following comment immediately after
discussing her own perceived low knowledge of chlamy-
dia:
“...but I don’t think many, like most people I know, I
don’t think they know all about this stuff so, I mean
they’re about my age ...I dunno...I just think it’s,
there’s just hardly any information about this and I
think there should be.”
(Interviewee #309, Female, Age 20, Workplace).
Although few interviewees could describe possible
sequelae, more women than men spoke of knowing the
potential fertility problems women could have following
chlamydial infection.
“I didn’t know any side effects or anything, apart
from infertility...it was the only one I knew, and I
didn’t know what symptoms there was or anything
like that.”
[sic] (Interviewee #255, Female, Age 22, Health &
Fitness).
Most interviewees, particularly the men, spoke of
being surprised to learn that the majority of people
would have no sign of symptoms of chlamydia infection.
“I was quite shocked by that, cos I always thought,
well for most things like that, that you’d know,
y’know. I always thought I would know, I’d have
some sort of symptom, so yeah, I was really surprised
when I read that most people don’t always know.”
(Interviewee #237, Male, Age 24, Health & Fitness)
The asymptomatic nature of the infection was the
commonest piece of information interviewees reported
as having learned from taking part in the study, and
indeed, as reported elsewhere [26], was among the rea-
sons for many being willing to provide a sample for test-
ing as part of the study:
R: I’d heard of chlamydia before I spoke to you but I
didn’t know that you might not know you have it. I’d
always thought that with things like this you’d know,
like you’d get a discharge or something would just be
like funny down there [laughs] but em, yeah I know
that that’s not always the case now and also that it
can cause like problems, women not getting pregnant
and stuff, I didn’t really know that
KL: You say you know those things from taking part
in this study?
R: Yeah, like you don’t always know or as you said
‘you can’t tell by looking’. I remember you saying
that to me.
(Interviewee #364, Male, Age 23, Workplace).
Most interviewees spoke about their own experience
of sex education and offered views on the quality of sex
education more generally. A typical view from both
male and female interviewees was that their low knowl-
edge about chlamydia was the ‘fault’ of their poor sex
education. A few couched their statements in normative
terms:
KL: what do you remember being taught about sex-
ual infections in sex education?
R: No much. I remember it was like AIDS and stuff
but that’s really all, HIV, that’s all I kind of remem-
ber. I think we really should have been taught about
this stuff, like see the first time really that I’ve ever
went into anything in any detail has been with
yourself.
(Interviewee #308, Male, Age 22, Workplace).
The most common STI interviewees remembered
being discussed during their sex education was HIV/
AIDS. Most interviewees commented that they did not
remember being taught about chlamydia at school.
Discussion
This study determined the level of awareness and
knowledge of chlamydia among young people who were
approached in a variety of community settings and
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offered opportunistic screening. The survey data
revealed a high awareness of chlamydia, which contrasts
with other survey work, which reports levels of aware-
ness of chlamydia in men and women to be around
50-60% [30-34]. These studies were with clinical popula-
tions but poor knowledge has also been reported among
non-clinical populations, including medical students,
other university students and school pupils, [35-37].
Nevertheless, whilst awareness was high, knowledge
decreased as questions became increasingly focussed, so
that the majority of respondents knew they could not
catch chlamydia from toilet seats but few knew chlamy-
dia could cause conjunctivitis.
The participant observation data, specifically the
recorded observations made during the initial approach
to young people, revealed gender differences in the
degree of certainty of having heard of chlamydia:
women immediately reported having heard of chlamy-
dia; in contrast, men were unsure and required prompt-
ing that it was a STI before recognising it and
confirming awareness. This lack of recognition among
men could have implications for social marketing
approaches, as men may not instantly recognise chlamy-
dia as an STI or consider it to be personally relevant.
These gender differences could have implications for
how young people are approached and offered chlamy-
dia screening. However, conveying information will
involve more than information provision as stigma and
embarrassment may reduce participation in screening
[26].
Gender differences in awareness extended to knowl-
edge of symptoms of chlamydia. The survey revealed
that a third of men and women were unaware of the
asymptomatic nature of chlamydia infection. Almost
half of men agreed with the statement ‘I’d only be con-
cerned about chlamydia if I had symptoms’. Poor knowl-
edge could lead to increased risk behaviour [38], and
negatively impact screening uptake as young people who
are better able to assess their own personal risk are
more likely to take up a screening offer [18]. However,
as reported elsewhere, [26] learning of the asymptomatic
nature of chlamydia was central to young people’s will-
ingness to be screened in this study, which reveals the
modifiable nature of their knowledge and the impor-
tance of this for subsequent participation. Others have
noted the tendency for those who develop minor symp-
toms to delay care seeking [39], and poor knowledge of
the potential implications of chlamydia infection for fer-
tility [34], which places greater importance on ensuring
that young people are aware of key aspects of chlamydia
infection. Participation in screening and uptake of repeat
testing are vital for early detection and treatment of
asymptomatic infections [11,40].
This Scottish study population is not exposed to chla-
mydia screening as part of a national screening pro-
gramme, thus our data are not necessarily generalisable
to other populations. Nevertheless opportunistic screen-
ing guidelines in Scotland (SIGN Guideline 109) recom-
mend screening as part of routine care in the same
clinical settings as the NCSP in England: community
contraception services, general practice, community
pharmacies and termination of pregnancy services [4].
Despite the NCSP in England, poor knowledge of the
issue is still present [25,35].
There are other limitations to this study. We used a
convenience sample for the survey, and it was difficult
to undertake purposive sampling for the qualitative
study. Despite the care taken by the researcher to ensure
a consistent approach to all age-eligible users it is possi-
ble that there was selection bias. In addition, recall and
social desirability biases may have been introduced, with
respondents perhaps selecting firm responses in the pre-
sence of their peers rather than answer ‘Don’t know’.
There could also have been conferring between partici-
pants when completing their questionnaires. It is possi-
ble that responses to some questionnaire items could
have been influenced by the information contained
within the study literature (leaflets and posters) as well
as the nature of the consent procedure - for example,
the leaflet detailed female symptoms and the question-
naire asked for knowledge of female symptoms. A ques-
tionnaire-based study which does not provide such prior
information about chlamydia could introduce less bias
to findings. These issues could bias the study and the
results should be interpreted in light of this. We did not
ask participants for information on their level of educa-
tion, so we do not know how far this might have
affected responses to questionnaire items on knowledge.
However, as noted above, poor knowledge has been
reported among young people recruited across a range
of settings [35-37], and this study found little setting-
effect on knowledge of symptoms. A strength is the qua-
litative data confirming the questionnaire responses,
including the gender differences in knowledge. Rigorous
recording of the outcome of each approach made to
young people was included in fieldnote diaries, which
revealed a high participation rate. The sample size and
variety of community settings used are also strengths.
Whilst the inclusion of men in screening has been
widely encouraged [41-43], this study shows that their
knowledge continues to be lower than that of women’s,
with little changing from earlier studies. Better ways to
inform young men of the key features of the infection
are vital if screening rates among men are to improve.
The implications of poor knowledge for disease control
are significant unless there is an improvement in young
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people’s understanding of this infection. To improve chla-
mydia detection and treatment innovative strategies have
been developed, including postal testing kits either mailed
proactively from general practice lists or made available
on the Internet for young people to request a kit and/or
log-on to receive a diagnosis [29,44,45]. Despite these
innovations, uptake remains poor. In order to maximise
gains from interventions to improve detection and treat-
ment, interventions are also required to increase young
people’s understanding of chlamydia, their assessment of
personal risk and to change health behaviours.
Conclusions
Communicating messages about the health risks asso-
ciated with chlamydia to young people represents a pub-
lic health challenge, particularly given the sexual nature
of its transmission, their lack of knowledge, and its high
prevalence in the target population. Greater efforts are
required to translate evidence into action, and to close
the gap between lay and professional knowledge regard-
ing chlamydia infection, its detection and treatment.
Additional material
Additional file 1: study leaflet. study leaflet given to potential
participants when first approached.
Additional file 2: Questionnaire. self-complete study questionnaire.
Additional file 3: topic guide.rtf. topic guide used during the in-depth
interviews.
Acknowledgements
Thanks to Prof Margaret Reid, now retired, who co-supervised this study.
Thanks to the participants of the study and Durex for supplying condoms to
provide to participants. The study was funded by the Chief Scientist Office
(Scottish Government), grant number CZS/1/25.
Author details
1Institute for Applied Health Research, Glasgow Caledonian University,
Glasgow, UK. 2Division of Population Health, University College London,
London, UK.
Authors’ contributions
GH had the original idea for the study and designed the study with KL and
was involved in the drafting of the paper; KL collected and analysed the
data and wrote the first draft of the paper. Both authors approved the final
version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 13 July 2010 Accepted: 30 December 2010
Published: 30 December 2010
References
1. The UK Collaborative Group for HIV and STI Surveillance: Testing Times.
HIV and other Sexually Transmitted Infections in the United Kingdom:
2007. London: Health Protection Agency, Centre for Infections; 2007.
2. Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Welling K,
Mercer CH, Carder C, Copas AJ, Nanchahal K, Macdowall W, Ridgway G,
Field J, Erens B: Sexual behaviour in Britain: reported sexually transmitted
infections and prevalent genital Chlamydia trachomatis infection. The
Lancet 2001, 358(9296):1851-1854.
3. Scottish Intercollegiate Guidelines Network (SIGN), Guideline 109:
Management of genital chlamydia trachomatis infection. Edinburgh,
United Kingdom; SIGN; 2009.
4. National Chlamydia Screening Programme: The Bigger Picture. The
National Chlamydia Screening Programme 2008/09 Annual Report.
[http://www.chlamydiascreening.nhs.uk/ps/assets/pdfs/publications/reports/
NCSPa-rprt-08_09.pdf], (accessed on 23 December 2010).
5. Stamm WE: Chlamydia trachomatis infections of the adult. In Sexually
transmitted diseases. 3 edition. Edited by: Holmes KK, Sparling PF, Mardh P,
Lemon SM, Piot P, Wasserheit JM. New York: McGraw Hill; 1999:407-422.
6. Information Services Division (ISD) Scotland: Sexually Transmitted
Infections and Other Sexual Health Information for Scotland. Edinburgh:
NHS National Services Scotland; 2007 [http://www.documents.hps.scot.nhs.
uk/bbvsti/sti/publications/sexual-health-2007.pdf], (accessed 23 December
2010).
7. Health Protection Agency. [http://www.hpa.org.uk/web/HPAwebFile/
HPAweb_C/1215589013442].
8. Low N, Harbord RM, Egger M, Sterne JAC, Herrmann B: Screening for
chlamydia. The Lancet 2005, 365(9470):1539.
9. NCSP Data Presentations 2009/10. [http://www.chlamydiascreening.nhs.uk/
ps/assets/pdfs/data/sha_presentations10/Q1-Q3%20National.pdf], (accessed
23 December 2010).
10. Low N, Bender N, Nartey L, Redmond S, Shang A, Stephenson J: Rapid
review of evidence for the effectiveness of screening for genital
chlamydia infection in sexually active young women and men. London:
National Institute for Health and Clinical Excellence; 2006.
11. Low N: Screening programmes for chlamydial infection: when will we
ever learn? BMJ 2007, 334(7596):725-728.
12. Hay S, Hay P, Oakeshott P: Feasibility of recruiting in a student bar for a
trial of chlamydia screening in young women. Family Practice 2004,
21(2):223.
13. Gunn RA, Podschun GD, Fitzgerald S, Hovell MF, Farshy CE, Black CM,
Greenspan JR: Screening high-risk adolescent males for Chlamydia
trachomatis infection: obtaining urine specimens in the field. Sexually
Transmitted Diseases 1998, 25(1):49.
14. Kahn RH, Moseley KE, Thilges JN, Johnson G, Farley TA: Community-based
screening and treatment for STDs: results from a mobile clinic initiative.
Sexually Transmitted Diseases 2003, 30(8):654.
15. Cohen DA, Nsuami M, Martin DH, Farley TA: Repeated school-based
screening for sexually transmitted diseases: a feasible strategy for
reaching adolescents. Pediatrics 1999, 104(6):1281.
16. Østergaard L, Andersen B, Møller JK, Olesen F: Home sampling versus
conventional swab sampling for screening of chlamydia trachomatis in
women: a cluster randomized 1 year follow up study. Clinical Infectious
Diseases 2000, 31:951-957.
17. Debattista J, Martin P, Jamieson J, Crane K, Dolton I, Russell-Hall S, DeSilva J,
Hargrave R, Robinson T, Ryan N: Detection of Chlamydia trachomatis in
an Australian high school student population. Sexually Transmitted
Infections 2002, 78(3):194.
18. Lorimer K, Reid ME, Hart GJ: Willingness of young men and women to be
tested for Chlamydia trachomatis in three non-medical settings in
Glasgow, UK. Journal of Family Planning and Reproductive Health Care 2009,
35(1):21-26.
19. Williamson LM, Scott G, Carrick-Anderson K, Kernaghan K, Hart GJ:
Chlamydia trachomatis testing among 13-25-year-olds in non-
genitourinary medicine settings. Journal of Family Planning and
Reproductive Health Care 2007, 33:177-182.
20. Macleod J, Salisbury C, Low N, McCarthy A, Sterne JAC, Holloway A, Patel R,
Sanford E, Morcom A, Horner P, Davey Smith G, Skidmore S, Herring A,
Caul O, Hobbs FDR, Egger M: Coverage and uptake of systematic postal
screening for genital Chlamydia trachomatis and prevalence of infection
in the United Kingdom general population: cross sectional study. BMJ
2005, 330(7497):940.
21. Novak DP, Edman AC, Jonsson M, Karlsson RB: The internet, a simple and
convenient tool in Chlamydia trachomatis screening of young people.
Euro Surveillance 2003, 8(9):171.
22. Andersen B, Olesen F, Moller JK, Ostergaard L: Population-based strategies
for outreach screening of urogenital Chlamydia trachomatis infections: a
randomized, controlled trial. J Infect Dis 2002, 185:252-258.
Lorimer and Hart BMC Public Health 2010, 10:794
http://www.biomedcentral.com/1471-2458/10/794
Page 8 of 9
23. Blake DR, Kearney MH, Oakes JM, Druker SK, Bibace R: Improving
Participation in Chlamydia Screening Programs: Perspectives of High-
Risk Youth. Arch Pediatr Adolesc Med 2003, 157(6):523-529.
24. Richardson D, Maple K, Perry N, Ambler E, Jurd C, Fisher M: A pilot
qualitative analysis of the psychosocial factors which drive young
people to decline chlamydia testing in the UK: implications for health
promotion and screening. Int J STD AIDS 2010, 21(3):187-190.
25. Chaudhary R, Heffernan CM, Illsley AL, Jarvie LK, Lattimer C, Nwuba AE,
Platford EW: Opportunistic screening for Chlamydia: a pilot study into
male perspectives on provision of Chlamydia screening in a UK
university. J Public Health 2008, 30(4):466-471.
26. Lorimer K, Reid ME, Hart GJ: “It has to speak to people’s everyday life":
qualitative study of men and women’s willingness to participate in a
non-medical approach to Chlamydia trachomatis screening. Sexually
Transmitted Infections 2009, 85(3):201-205.
27. Balfe M, Brugha R: What prompts young adults in Ireland to attend
health services for STI testing? BMC Public Health 2009, 9:10.
28. Buston K, Wight D: Self-reported sexually transmitted infection testing
behaviour amongst incarcerated young male offenders: findings from a
qualitative study. Journal of Family Planning and Reproductive Health Care
2010, 36(1):7-11.
29. Mills N, Daker-White G, Graham A, Campbell R: Population screening for
Chlamydia trachomatis infection in the UK: a qualitative study of the
experiences of those screened. Family Practice 2006, 23(5):550.
30. Devonshire P, Hillman R, Capewell S, Clark BJ: Knowledge of Chlamydia
trachomatis genital infection and its consequences in people attending
a genitourinary medicine clinic. Sexually Transmitted Infections 1999,
75(6):409-411.
31. Kellock DJ, Piercy H, Rogstad KE: Knowledge of Chlamydia trachomatis
infection in genitourinary medicine clinic attenders. Sexually Transmitted
Infections 1999, 75(1):36-40.
32. Macmillan S, Walker R, Oloto E, Fitzmaurice A, Templeton A: Ignorance
about Chlamydia among sexually active women–a two centre study.
Hum Reprod 1999, 14(4):1131-1135.
33. Griesinger G, Gille G, Klapp C, Von Otte S, Diedrich K: Sexual behaviour
and Chlamydia trachomatis infections in German female urban
adolescents, 2004. Clinical Microbiology and Infection 2007, 13(4):436-439.
34. Pavlin NL, Gunn JM, Parker R, Fairley CK, Hocking J: Implementing
chlamydia screening: what do women think? A systematic review of the
literature. BMC Public Health 2006, 6:11.
35. Greaves A, Lonsdale S, Whinney S, Hood E, Mossop H, Olowokure B:
University undergraduates’ knowledge of chlamydia screening services
and chlamydia infection following the introduction of a National
Chlamydia Screening Programme. European Journal of Contraception and
Reproductive Health Care 2009, 14(1):61-68.
36. Fayers T, Crowley T, Jenkins JM, Cahill DJ: Medical student awareness of
sexual health is poor. Int J STD AIDS 2003, 14(6):386-389.
37. Mason L: Knowledge of sexually transmitted infections and sources of
information amongst men. J R Soc Promot Health 2005, 125(6):266-271.
38. Andersson-Ellström A, Milsom I: Knowledge about the prevention of
sexually transmitted diseases: a longitudinal study of young women
from 16-23 years of age. Sexually Transmitted Infections 2002,
78(5):339-341.
39. Darroch J, Myers L, Cassell J: Sex differences in the experience of testing
positive for genital chlamydia infection: a qualitative study with
implications for public health and for a national screening programme.
Sexually Transmitted Infections 2003, 79(5):372-373.
40. Department of Health: National Chlamydia Screening Programme (NSCP)
Core Requirements. 5 edition. London: DoH; 2010.
41. Fenton KA: Screening men for Chlamydia trachomatis infection: have we
fully explored the possibilities? Communicable Disease and Public Health
2000, 3(2):86-89.
42. Ford CA, Viadro CI, Miller WC: Testing for Chlamydial and Gonorrheal
Infections Outside of Clinic Settings: A Summary of the Literature.
Sexually Transmitted Diseases 2004, 31(1):38-51.
43. Duncan B, Hart G: Sexuality and health: the hidden costs of screening for
Chlamydia trachomatis. BMJ 1999, 318(7188):931-933.
44. McCadden A, Fenton KA, McManus S, Mercer CH, Erens B, Carder C,
Ridgway G, Macdowall W, Nanchahal K, Byron CL, Copas A, Wellings K,
Johnson AM: Chlamydia trachomatis Testing in the Second British
National Survey of Sexual Attitudes and Lifestyles: Respondent Uptake
and Treatment Outcomes. Sexually Transmitted Diseases 2005,
32(6):387-394.
45. Novak DP, Karlsson RB: Simplifying chlamydia testing: an innovative
Chlamydia trachomatis testing approach using the internet and a home
sampling strategy: population based study. Sexually Transmitted Infections
2006, 82(2):142-147.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2458/10/794/prepub
doi:10.1186/1471-2458-10-794
Cite this article as: Lorimer and Hart: Knowledge of Chlamydia
trachomatis among men and women approached to participate in
community-based screening, Scotland, UK. BMC Public Health 2010
10:794.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lorimer and Hart BMC Public Health 2010, 10:794
http://www.biomedcentral.com/1471-2458/10/794
Page 9 of 9
